Table 2.
The relationship between AKNA expression level and clinicopathological factors in 32 GC cases.
| Characteristics | N = 32 | Expression of AKNA | χ2 | P | |
|---|---|---|---|---|---|
| Low (N = 16) | High (N = 16) | ||||
| Gender | 0.685∗ | ||||
| Male | 24 | 13 (54.2%) | 11 | ||
| Female | 8 | 3 (37.5%) | 5 | ||
| Age(years) | 4.800 | 0.028 | |||
| ≤60 | 12 | 9 (75.0%) | 3 | ||
| >60 | 20 | 7 (35.0%) | 13 | ||
| Borrmann's types | 0.433∗ | ||||
| I+II | 9 | 6 (66.7%) | 3 | ||
| III | 23 | 10 (43.5%) | 13 | ||
| Lauren's types | 0.533 | 0.465 | |||
| Intestinal type | 12 | 7 (58.3%) | 5 | ||
| Diffuse type | 20 | 9 (45.0%) | 11 | ||
| Depth of invasion | 3.463 | 0.063 | |||
| T1~T3 | 11 | 3 (27.3%) | 8 | ||
| T4 | 21 | 13 (61.9%) | 8 | ||
| Ln metastasis | 8.533 | 0.003 | |||
| N0 | 12 | 2 (16.7%) | 10 | ||
| N1~N3 | 20 | 14 (70.0%) | 6 | ||
| Distant metastasis | 1.000∗ | ||||
| M0 | 31 | 15 (48.4%) | 16 | ||
| M1 | 1 | 1 (100%) | 0 | ||
| TNM staging | 1.166 | 0.280 | |||
| I+II | 13 | 5 (38.5%) | 8 | ||
| III+IV | 19 | 11 (57.9%) | 8 | ||
∗Fisher's exact test. Ln.: lymph node.